Contact Us
Drug Search Results
More Filters [+]

PBF-680

Alternative Names: pbf-680, pbf680, pbf 680
Latest Update: 2024-04-19
Latest Update Note: Clinical Trial Update

Product Description

Adenosine A1 Antagonist for Asthma and COPD (Sourced from: https://www.palobiofarma.com/pipeline-2/)

Mechanisms of Action: ADORA1 Antagonist

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Palobiofarma SL
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for PBF-680

Countries in Clinic: Spain

Active Clinical Trial Count: 3

Highest Development Phases

Phase 2: Asthma|Chronic Obstructive Pulmonary Disease

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success
Respire

P2

Completed

Chronic Obstructive Pulmonary Disease

2024-02-27

35%
2021-001732-25

P2

Active, not recruiting

Chronic Obstructive Pulmonary Disease

2023-01-07

2017-003663-35

P2

Active, not recruiting

Asthma

2019-02-14

Recent News Events

Date

Type

Title

09/26/2019

News Article

 XOMA Acquires Royalty Interest Position in Six Clinical-Stage Assets

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions